Propanc Biopharma, Inc. Common Stock
$0.61
Market Cap
$1.39M
Shares Outstanding
2.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 15, 2012
Round Lot
100
Locale
US
Day Open
$0.66
Day High
$0.67
Day Low
$0.60
Volume
160.5K
VWAP
$0.64
Prev Close
$0.63
Transactions
--
Acc. Volume
--
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Propanc Biopharma, Inc. Common Stock (PPCB) closed the 2026-09-18 session at $0.61, down 3.17% versus the previous close (-0.02). The stock opened at $0.66 and traded between $0.60 and $0.67 during that session. Session trading volume was 161K shares. The volume-weighted average price (VWAP) is $0.64.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Propanc Biopharma, Inc. Common Stock has a market capitalization of $1.4 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. PPCB is listed on the XNAS exchange. The company employs approximately 2 people. Propanc Biopharma, Inc. Common Stock is headquartered in CAMBERWELL, VICTORIA, C3. The recorded listing date is 2012-06-15.
On this page you can find market PPCB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.